Progesterone Side Effects During Perimenopause: A Guide to Managing Them
A practical guide to progesterone and progestogen side effects in perimenopause HRT, including mood changes, bloating, spotting, and timing strategies.
Why Progesterone Causes Its Own Set of Side Effects
Progesterone is the second key hormone in combined HRT for women with a uterus, added to oestrogen to protect the uterine lining from overgrowth. While much attention focuses on oestrogen and its side effects, progestogen intolerance is among the most common reasons women struggle with combined HRT and, for some, abandon it entirely. Understanding why progesterone causes side effects helps enormously in finding solutions. Progesterone and synthetic progestogens act on multiple receptor types throughout the body beyond the uterus, including in the brain, nervous system, skin, and gut. This broad action explains the range of effects women experience, from mood changes and low energy to bloating, breast tenderness, and disrupted sleep. The severity of these side effects varies considerably between women. Some women take progesterone with no noticeable effects at all. Others find the progestogen phase of a sequential regimen significantly disruptive. Individual sensitivity to progestogen is likely partly genetic and is influenced by prior hormonal history, including responses to the progesterone-dominant luteal phase of the natural cycle, or to progestogen-containing contraceptives. Women who had severe premenstrual syndrome or who struggled with progestogen-based contraceptives tend to be more sensitive to progestogen side effects in HRT.
Mood Changes and Psychological Effects
Mood-related side effects are the most commonly reported and often the most disruptive consequence of the progestogen component of HRT. Women describe low mood, irritability, anxiety, tearfulness, difficulty concentrating, fatigue, and a sense of emotional flatness during the progestogen phase of sequential HRT. These symptoms can feel remarkably similar to severe premenstrual syndrome. In some cases they are severe enough to cause significant impairment at work or in relationships. The mechanism involves progesterone's metabolites, particularly allopregnanolone, which interacts with GABA receptors in the brain. In women with neurological sensitivity to progesterone fluctuations, this interaction can produce a depressive or anxious response. Synthetic progestogens such as norethisterone and medroxyprogesterone acetate also have androgenic properties, which can contribute to mood changes, acne, and irritability. Micronised progesterone (Utrogestan), by contrast, generates more allopregnanolone and tends to have a calmer, sometimes mildly sedating effect rather than an agitating one. Switching from a synthetic progestogen to micronised progesterone is the single most effective change for women experiencing progestogen-related mood symptoms.
Bloating, Breast Tenderness, and Other Physical Side Effects
Physical side effects from progesterone can mirror the second half of the natural menstrual cycle for women who had significant premenstrual physical symptoms. Bloating is a common complaint and tends to be worse in the progestogen phase of sequential HRT. It is caused partly by progesterone's slowing effect on gut motility, which allows more time for gas production and accumulation. Eating smaller meals more frequently, reducing high-FODMAP foods during the progestogen phase, and staying well hydrated can help. Breast tenderness is often more pronounced during the progestogen phase than during oestrogen-only periods. Progesterone stimulates breast tissue directly, and this stimulation causes swelling and sensitivity. Reducing caffeine intake and wearing a supportive bra can ease the discomfort. Some women experience headaches, particularly at the end of the progestogen phase or when transitioning off it, as progesterone levels drop. If these headaches are severe or migrainous, taking micronised progesterone vaginally rather than orally is an option worth discussing with a GP, as vaginal administration reduces systemic absorption and systemic side effects while still protecting the uterine lining.
Micronised Progesterone vs Synthetic Progestogens
The choice of progestogen is one of the most impactful variables in combined HRT and deserves careful attention. Synthetic progestogens, including norethisterone, levonorgestrel, and medroxyprogesterone acetate, are structurally different from natural progesterone. They are effective at endometrial protection but interact with a broader range of receptor types, which explains their more pronounced side effect profiles. Norethisterone, one of the most commonly used synthetic progestogens, has androgenic properties that can cause acne, oily skin, mood disruption, and libido changes in some women. Micronised progesterone (Utrogestan) is structurally identical to the progesterone the body makes. It has a more selective receptor affinity and a more predictable side effect profile. When taken orally, it is broken down in the gut into neurosteroid metabolites that can cause mild drowsiness, which is why many women take it at bedtime. This drowsiness, which can be inconvenient if taken during the day, becomes an advantage for women who struggle with sleep. The 2019 Collaborative Group meta-analysis and the E3N French cohort study both suggest micronised progesterone carries a lower breast cancer risk than synthetic progestogens, adding further clinical reason to prefer it. It is now available on the NHS but prescribing varies by area.
Timing Strategies to Reduce Side Effects
When and how progesterone is taken can significantly influence the experience of side effects. For women using micronised progesterone capsules, taking them at bedtime rather than in the morning is the most widely recommended approach. The sedating effect of the neurosteroid metabolites is not disruptive at night and many women find their sleep quality actually improves. Vaginal administration of micronised progesterone is another option: the capsule is inserted vaginally rather than swallowed, which achieves high local concentrations in the uterus with much lower systemic blood levels. This dramatically reduces systemic side effects such as drowsiness, mood changes, and headaches while maintaining full endometrial protection. It is particularly useful for women who are highly sensitive to progesterone side effects when taken orally. For women on sequential HRT using a synthetic progestogen, moving the progestogen phase to a different part of the month, or switching to a preparation where progestogen and oestrogen are combined in a patch, can make the regimen feel more consistent and reduce the contrast between phases. Some women find a shorter progestogen phase (10 days instead of 14) reduces side effect exposure while still providing adequate endometrial protection, though this should be discussed with a prescriber.
When to Consider Switching to the Mirena Coil
For women who experience significant progestogen side effects from oral or transdermal synthetic progestogens, the Mirena IUS (hormonal coil) offers a fundamentally different delivery method. The Mirena releases a very low daily dose of levonorgestrel directly into the uterus, producing high local concentrations in the uterine lining with minimal systemic absorption. This means it provides robust endometrial protection without the systemic side effects associated with oral or transdermal synthetic progestogens. Blood levels of levonorgestrel from the Mirena are extremely low, typically lower than from any oral preparation. Many women who have struggled with progestogen side effects from oral preparations find the Mirena dramatically improves their HRT experience. It is particularly useful for women who have significant mood sensitivity to progestogen, or who simply prefer not to manage a daily tablet. The Mirena lasts five years (with some data supporting up to seven years for the endometrial protection indication in older women), making it a convenient long-term solution. It also provides reliable contraception, which matters for perimenopausal women who are not yet past the age of needing contraception. The insertion procedure requires a GP or gynaecology appointment and may cause cramping for a day or two, but this is a one-time cost for years of improved HRT tolerability.
Related reading
Get your personalized daily plan
Track symptoms, match workouts to your day type, and build a routine that adapts with you through every phase of perimenopause.